On March 5, Japan unveiled new NHI prices for the FY2024 drug price revision. A Jiho survey found that Tsumura, a specialist in Japanese Kampo herbal medicines, received an astonishing raise of over 24% in its drug prices on a…
HOME > TRENDS
TRENDS
- Most Global Products on Track to Clear Their FY2014 Sales Forecasts; Abilify Posting Sales of 650 Billion Yen
March 16, 2015
- Will SGLT-2 Inhibitors Catch On? Breakout Will Require Accumulation of Data
February 25, 2015
- Chugai Aims to Surpass 200 Billion Yen in Its Domestic Oncology Sales in 2015
February 13, 2015
- EFPIA Predicts Growth in Ethical Drug Market to Just 10 Trillion Yen in 2025
February 6, 2015
- Edoxaban Approved in US with Restriction on Use; Impact on Daiichi Sankyo’s Midterm Business Plan Remains Unclear
January 30, 2015
- Pneumococcal Vaccine Market Expanding with Inclusion in Publicly-Funded Vaccination Programs
January 16, 2015
- Drug Makers Continue Trial and Error Efforts to Improve Lecture Meetings
January 9, 2015
- ARBs at a Turning Point: Inroads by Generics to Lead to Gradual Decline in Sales
December 26, 2014
- Pharmacist Society Criticizes Inappropriate Phrases in Materials Used by Sales Reps, Questions Use of Misleading Terms
December 19, 2014
- Sales of Biosimilar EPO, G-CSF Growing as Awareness Increases
December 12, 2014
- Industry Insiders, Healthcare Providers Call for Greater Focus on PMS by MRs, Criticize Excessive Focus on Product Promotion
December 5, 2014
- Chugai’s Alecensa Off to a Good Start with Sales of 200 Million Yen in 1st Month
November 28, 2014
- Bayer Sets Target of 30% Growth in Group Sales in Japan within 4 Years; Success to Depend Largely on 2 Core Products
November 21, 2014
- Sales of Most Long-Listed Drugs Fall Short of Forecasts in Apr.-Sept.; Over 70% See Downward Revisions in Full-year Forecasts
November 11, 2014
- Chugai Led in Research Grants Payment in FY2013; Grants Fell Among Major Drug Makers
November 5, 2014
- Will Blopress AG Face Price War After Other Generics Debut in December?
November 5, 2014
- Topical Combination Psoriasis Treatment Dovobet Debuts; Expected to Improve Patient QOL, Medication Adherence
October 31, 2014
- Changes in Business Environment Spur Drug Makers to Reform Their Marketing Systems, Adopt Area Marketing Systems
October 22, 2014
- LEP Agents Contributing to Expansion of Oral Contraceptives Market, Growing Use of Low-Dose Pill
October 10, 2014
- Facing Unprecedented Patent Cliff for Abilify, Otsuka Holdings Sets Forth Plan to Achieve Recovery in 2018
September 24, 2014
ページ
Too often, recruiters are more clear on what a position will “do” rather than what it will “achieve”.Outlining tasks and responsibilities takes priority over goals and impact.But to attract top talent, you need to define and explain what success looks…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…